View in EDS PDF Full Text

Docetaxel plus cetuximab biweekly is an active regimen for the first-line treatment of patients with recurrent/metastatic head and neck cancer.

Saved in:
Bibliographic Details
Title: Docetaxel plus cetuximab biweekly is an active regimen for the first-line treatment of patients with recurrent/metastatic head and neck cancer.
Authors: Posch, Doris1, Fuchs, Hannah1, Kornek, Gabriela1, Grah, Anja1, Pammer, Johannes2, Aretin, Marie-Bernadette3, Fuereder, Thorsten1
Source: Scientific Reports. 9/9/2016, p32946. 1p.
Database: Academic Search Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 117988396
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Docetaxel plus cetuximab biweekly is an active regimen for the first-line treatment of patients with recurrent/metastatic head and neck cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Posch%2C+Doris%22">Posch, Doris</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Fuchs%2C+Hannah%22">Fuchs, Hannah</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Kornek%2C+Gabriela%22">Kornek, Gabriela</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Grah%2C+Anja%22">Grah, Anja</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Pammer%2C+Johannes%22">Pammer, Johannes</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22Aretin%2C+Marie-Bernadette%22">Aretin, Marie-Bernadette</searchLink><relatesTo>3</relatesTo><br /><searchLink fieldCode="AR" term="%22Fuereder%2C+Thorsten%22">Fuereder, Thorsten</searchLink><relatesTo>1</relatesTo>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Scientific+Reports%22">Scientific Reports</searchLink>. 9/9/2016, p32946. 1p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=117988396
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/srep32946
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 1
        StartPage: 32946
    Titles:
      – TitleFull: Docetaxel plus cetuximab biweekly is an active regimen for the first-line treatment of patients with recurrent/metastatic head and neck cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Posch, Doris
      – PersonEntity:
          Name:
            NameFull: Fuchs, Hannah
      – PersonEntity:
          Name:
            NameFull: Kornek, Gabriela
      – PersonEntity:
          Name:
            NameFull: Grah, Anja
      – PersonEntity:
          Name:
            NameFull: Pammer, Johannes
      – PersonEntity:
          Name:
            NameFull: Aretin, Marie-Bernadette
      – PersonEntity:
          Name:
            NameFull: Fuereder, Thorsten
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 09
              M: 09
              Text: 9/9/2016
              Type: published
              Y: 2016
          Identifiers:
            – Type: issn-print
              Value: 20452322
          Titles:
            – TitleFull: Scientific Reports
              Type: main
ResultId 1